DK267686D0 - Difluorketonpeptidderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne - Google Patents

Difluorketonpeptidderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne

Info

Publication number
DK267686D0
DK267686D0 DK267686A DK267686A DK267686D0 DK 267686 D0 DK267686 D0 DK 267686D0 DK 267686 A DK267686 A DK 267686A DK 267686 A DK267686 A DK 267686A DK 267686 D0 DK267686 D0 DK 267686D0
Authority
DK
Denmark
Prior art keywords
derivatives
difluorcoetone
procedures
preparing
peptide
Prior art date
Application number
DK267686A
Other languages
English (en)
Other versions
DK267686A (da
Inventor
Diane Amy Trainor
Mark Morris Stein
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858514440A external-priority patent/GB8514440D0/en
Priority claimed from GB858514436A external-priority patent/GB8514436D0/en
Priority claimed from GB858514438A external-priority patent/GB8514438D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of DK267686D0 publication Critical patent/DK267686D0/da
Publication of DK267686A publication Critical patent/DK267686A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
DK267686A 1985-06-07 1986-06-06 Difluorketonpeptidderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne DK267686A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858514440A GB8514440D0 (en) 1985-06-07 1985-06-07 Difluoro ketone tripeptide derivatives
GB858514436A GB8514436D0 (en) 1985-06-07 1985-06-07 Selected difluoro derivatives
GB858514438A GB8514438D0 (en) 1985-06-07 1985-06-07 Selected difluoro ketone dipeptide derivatives

Publications (2)

Publication Number Publication Date
DK267686D0 true DK267686D0 (da) 1986-06-06
DK267686A DK267686A (da) 1986-12-08

Family

ID=27262698

Family Applications (1)

Application Number Title Priority Date Filing Date
DK267686A DK267686A (da) 1985-06-07 1986-06-06 Difluorketonpeptidderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne

Country Status (16)

Country Link
US (1) US4880780A (da)
EP (1) EP0204571B1 (da)
JP (1) JPH07116159B2 (da)
AT (1) ATE71934T1 (da)
AU (1) AU594683B2 (da)
DE (1) DE3683541D1 (da)
DK (1) DK267686A (da)
ES (4) ES8801305A1 (da)
FI (1) FI86859C (da)
GR (1) GR861488B (da)
HU (1) HU208438B (da)
IE (1) IE59146B1 (da)
IL (1) IL79049A0 (da)
NO (1) NO170585C (da)
NZ (1) NZ216437A (da)
PT (1) PT82724B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
GB8711748D0 (en) * 1986-06-05 1987-06-24 Ici America Inc Difluoro keto compounds
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
EP0371179A1 (en) * 1988-10-28 1990-06-06 Merrell Dow Pharmaceuticals Inc. Novel analogs of peptidase substrates
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
WO1992020357A1 (en) * 1991-05-23 1992-11-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5486529A (en) * 1992-04-16 1996-01-23 Zeneca Limited Certain pyridyl ketones for treating diseases involving leukocyte elastase
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
EP0763055B1 (en) * 1994-06-02 1999-11-03 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
FI964781A7 (fi) * 1994-06-02 1997-01-29 Aventis Pharma Inc Uusia elastaasi-inhibiittoreita
DE69522940T2 (de) * 1994-06-02 2002-04-04 Merrell Pharmaceuticals Inc., Cincinnati Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
AP1019A (en) 1996-10-18 2001-10-16 Vertex Pharma Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
UY28500A1 (es) 2003-09-05 2005-04-29 Vertex Pharma Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
AU2007217355B2 (en) 2006-02-27 2012-06-21 Vertex Pharmaceuticals Incorporated Co-crystals comprising VX-950 and pharmaceutical compositions comprising the same
WO2007109080A2 (en) * 2006-03-16 2007-09-27 Vertex Pharmaceuticals Incorporated Deuterated hepatitis c protease inhibitors
CA2669917A1 (en) * 2006-11-17 2008-05-22 Dawn M. George Aminopyrrolidines as chemokine receptor antagonists
WO2008106058A2 (en) 2007-02-27 2008-09-04 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
HRP20120330T1 (hr) 2007-02-27 2012-05-31 Vertex Pharmaceuticals Incorporated Sukristali i farmaceutski pripravci koji ih sadrže
NZ583699A (en) 2007-08-30 2012-04-27 Vertex Pharma Co-crystals of vx-950 (telaprevir) other components and pharmaceutical compositions comprising the same
WO2011025964A2 (en) 2009-08-29 2011-03-03 Abbott Laboratories Therapeutic dll4 binding proteins
BR112012021941A2 (pt) 2010-03-02 2022-02-01 Abbvie Inc Proteínas terapêuticas de ligação a dll4
US8735546B2 (en) 2010-08-03 2014-05-27 Abbvie Inc. Dual variable domain immunoglobulins and uses thereof
KR20180008921A (ko) 2012-11-01 2018-01-24 애브비 인코포레이티드 항-ｖｅｇｆ／ｄｌｌ4 이원 가변 도메인 면역글로불린 및 이의 용도
WO2016094881A2 (en) 2014-12-11 2016-06-16 Abbvie Inc. Lrp-8 binding proteins
TW201713613A (zh) * 2015-05-11 2017-04-16 赫孚孟拉羅股份公司 新二氟酮醯胺衍生物
TW201710286A (zh) 2015-06-15 2017-03-16 艾伯維有限公司 抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
EP3994148A1 (en) * 2019-07-01 2022-05-11 Basf Se Peptide acetals for stabilising enzymes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
US3935280A (en) 1975-01-10 1976-01-27 Aldrich-Boranes, Inc. Reduction of amino acids in the presence of boron trifluoride
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
EP0124317B1 (en) 1983-04-27 1990-04-11 Ici Americas Inc. Proline derivatives
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives

Also Published As

Publication number Publication date
FI86859B (fi) 1992-07-15
ES8801305A1 (es) 1987-12-16
ES8900051A1 (es) 1988-11-16
ES8802321A1 (es) 1988-05-01
NO170585B (no) 1992-07-27
GR861488B (en) 1986-09-05
ES557735A0 (es) 1988-05-01
FI862434A7 (fi) 1986-12-08
NO862269L (no) 1986-12-08
IE861513L (en) 1986-12-07
JPH07116159B2 (ja) 1995-12-13
JPS6253951A (ja) 1987-03-09
HUT40811A (en) 1987-02-27
ATE71934T1 (de) 1992-02-15
ES557733A0 (es) 1988-09-01
FI862434A0 (fi) 1986-06-06
AU594683B2 (en) 1990-03-15
IL79049A0 (en) 1986-09-30
EP0204571A3 (en) 1988-09-21
DE3683541D1 (de) 1992-03-05
HU208438B (en) 1993-10-28
ES8802619A1 (es) 1988-09-01
ES557734A0 (es) 1988-11-16
EP0204571A2 (en) 1986-12-10
AU5845486A (en) 1986-12-18
ES555826A0 (es) 1987-12-16
IE59146B1 (en) 1994-01-12
FI86859C (fi) 1992-10-26
PT82724B (pt) 1988-12-15
NO862269D0 (no) 1986-06-06
DK267686A (da) 1986-12-08
PT82724A (en) 1986-07-01
US4880780A (en) 1989-11-14
NZ216437A (en) 1990-06-26
NO170585C (no) 1992-11-04
EP0204571B1 (en) 1992-01-22

Similar Documents

Publication Publication Date Title
DK267686A (da) Difluorketonpeptidderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
ES8706169A1 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
FI891716A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa
IL78940A0 (en) Pharmaceutical compositions for treating allergy comprising arylalkyl-heterocyclic amines n-substituted by aryloxyalkyl groups
GR20010300006T1 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
FI893962A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat hyödyllisiä AIDS:in hoidossa
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
FI963132A7 (fi) Diastereomeerisesti puhtaat trifluorimetyyliketonipeptidijohdannaiset ihmisen leukosyyttielastaasin inhibiittoreina
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
ES2063796T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
BR9909237A (pt) Inibidores de farnesil-proteìna transferase
ATE84043T1 (de) Aminosaeurederivate.
ATE90359T1 (de) Peptide.
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
DK639887D0 (da) Farmaceutiske praeparater
SE9000793D0 (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
FI932650A7 (fi) B-solujen maligniteettien hoitoon tarkoitetut farmaseuttiset seokset
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
GEP19991605B (en) Inhibitor, Its Obtaining and Use
ATE18132T1 (de) Pharmazeutische praeparate zur behandlung von nagelentzuendungen.
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
IL89235A0 (en) Pharmaceutical compositions for treating allergy comprising arylalkyl-heterocyclic amines n-substituted by aryloxyalkyl

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment